Shine On You Crazy ...
Health Care: Drugs
Arrowhead Research Corporation (ARWR: NASDAQ)
$2.16 0.03 | 1.41%
05/21/13 - 12:17 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.13 |
| 52 Week High | 4.47 |
| 52 Week Low | 1.65 |
| Avg. Daily Vol. (Mil) | 0.13 |
| Beta (3 year) | 1.75 |
| Share Related Items | |
| Mkt Cap (Mil) | 66.68 |
| Shares Out (Mil) | 31.31 |
| Float (Mil) | 16.97 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.50 |
| Current Ratio | 0.50 |
| LT Debt/ Equity | 0.23 |
| Total Debt / Equity | 0.44 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 226.47 |
| Price/Book | 12.55 |
| Price/Cash Flow | -2.80 |
| Per Share Data | |
| Earnings | -1.87 |
| Sales | 0.01 |
| Book Value | 0.17 |
| Cash Flow | -0.76 |
| Business Summary | |
|---|---|
| Arrowhead Research Corporation is a development stage nanotechnology holding company that forms, acquires, and operates subsidiaries commercializing innovative nanotechnologies. | |
| General Information | |
| 225 South Lake Avenue
Suite 1050 Pasedena, CA 91101 |
|
| www.arrowheadresearch.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 52 | |
| CEO: Dr. Christopher Anzalone | |
| Short Interest | |
| Current Month (Mil) | 0.81 |
| Previous Month (Mil) | 0.87 |
| Short Interest Ratio (Days) | 12.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -205.80 |
| Return on Investments | -391.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ARWR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Usertest1123
- ContributorStocks Under-$10 Setting Up...
- UserKJP 2012 Carbon Flash Fund
- Contributor8 Penny Stocks Get Delistin...
- UserWilliam T Blanchard - Medical
- UserCaroline
- UserSimon $9000
- Usertreneehill's pennies
Latest ARWR Headlines from TheStreet
- 5 Health Care Stocks Under $10 to Watch 04.30.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 4 Biotech Stocks Under $10 Moving Higher 02.20.13 | 09:02 pm
- 5 Stocks Under $10 Set to Trade Higher in November 11.01.12 | 01:11 pm
- Arrowhead's Management Presents At 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript) 08.14.12 | 09:08 pm
- Arrowhead Research Corporation's CEO Discusses F3Q12 Results - Earnings Call Transcript 08.13.12 | 08:08 pm
- Arrowhead Research's CEO Hosts Alvos Acquisition Conference Call (Transcript) 05.08.12 | 12:05 am
- 6 Stocks Hitting New 52-Week Highs 11.10.11 | 01:11 pm
- 8 Penny Stocks Get Delisting Warning 01.04.11 | 07:01 am
- Arrowhead Research CEO Discusses F4Q2010 Results  Earnings Call Transcript 12.22.10 | 09:12 pm
Press Releases for ARWR
- Arrowhead Induces 90% Reduction In Hepatitis B Antigens In Chimpanzee With Chronic Infection: Data Follow Previous Report Of Reduction In Viral DNA - Business Wire 03.25.13 | 07:03 am
- Arrowhead RNAi Candidate ARC-520 Induces Greater Than 90% Reduction In Circulating HBV DNA In Chimpanzee With Chronic Hepatitis B - Business Wire 03.14.13 | 07:03 am
- Arrowhead To Host Analyst Event In New York To Discuss RNAi-based Hepatitis B Candidate ARC-520 - Business Wire 03.07.13 | 07:03 am
- Arrowhead Receives Notice Of Patent Allowance For New Protease Sensitive Masking Chemistry For DPC SiRNA Delivery System - Business Wire 02.28.13 | 07:02 am
- Arrowhead Data Demonstrates RNAi Candidate ARC-520 Silences Hepatitis B Virus - Business Wire 02.26.13 | 09:02 am
- Arrowhead Reports Fiscal 2013 First Quarter Financial Results - Business Wire 02.13.13 | 04:02 pm
- Lifshitz Law Firm Announces Investigation Of Arrowhead Research Corp., MEI Pharma, Inc., Park City Group, Inc., And The Toro Company - PR Newswire 02.07.13 | 05:02 pm
- Arrowhead To Report Fiscal 2013 First Quarter Financial Results - Business Wire 02.06.13 | 07:02 am
- Arrowhead To Present At Upcoming Scientific Conferences - Business Wire 02.01.13 | 07:02 am
- Arrowhead Announces Pricing Of A Public Offering Of Common Stock And Warrants - Business Wire 01.25.13 | 09:01 am
Partner Headlines for ARWR
- Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency - Benzinga 10.16.12 | 09:10 am
- Arrowhead Sells 2.3M Shares, 1.7M Warrants for $6.2M - Benzinga 08.13.12 | 09:08 am
- Anti-Obesity Drug CAUSES Trouble for Arrowhead and 4 Stocks that Have Hit 52-Week Lows - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- 4 Smaller Alternatives to Big Pharma Obesity Treatments - Benzinga 05.25.12 | 01:05 pm
- Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts - Seeking Alpha 03.07.12 | 08:03 am
- Arrowhead Reports Q1 EPS of $(0.02) - Benzinga 02.10.11 | 04:02 pm
- UPDATE 1-Arrowhead co, Smith & Nephew to make cartilage product - Reuters 10.18.10 | 08:10 am
